thesis supervisor |
research topic |
deadline for application |
location of studies (in Hungarian) |
|---|
  |
|
 |
|
| Andrea Párniczky | Investigation of the pathomechanism and the clinical course of acute pancreatitis in adults and children | 2024-09-30 | SE |
| Andrea Párniczky | Genetic analysis of pediatric pancreatitis. The APPLE (Analysis of pediatric pancreatitis) multicentric, multinational, observational clinical trial | 2024-09-30 | SE |
| Andrea Párniczky | Investigation of the epidemiology, diagnostics, treatment, complications and genetic background of SARS-CoV-2 induced disease | 2024-09-30 | SE |
| Péter Petschner | Omics-based investigations of polygenic central nervous system disorders | 2024-09-30 | SE DI |
| Péter Petschner | Application of artificial intelligence algorithms for novel drug target discovery in polygenic disorders | 2024-09-30 | SE DI |
| Tamás Tábi | Study of degenerative mechanisms and effect of cytoprotective compounds | 2024-09-30 | SE |
| György Bagdy | Associations of disorders, pharmacotherapy and biology using large human databases | 2024-09-30 | SE |
| György Tibor Balogh | Development of Cyclodextrin-based Targeted Drug Delivery Systems | 2024-09-30 | SE |
| Orsolya Cseprekál | Novel approaches of outcome prediction in kidney transplantation | 2024-09-30 | SE |
| Bálint Mihály Erőss | The clinical aspects of gastrointestinal bleeding | 2024-09-30 | SE |
| Ida Fejős | Complex formation studies of natural compounds | 2024-09-30 | SE |
| Péter Jenő Hegyi | Investigation of chronic liver disease effect on outcomes in acute pancreatitis | 2024-09-30 | SE |
| Péter Hegyi | Investigation of the early phase of acute and chronic pancreatitis: from bed to the bench side research | 2024-09-30 | SE |
| Péter Jenő Hegyi | Investigation of chronic liver disease effect on outcomes in acute pancreatitis | 2024-09-30 | SE |
| Péter Hegyi | Investigation of the early phase of acute and chronic pancreatitis: from bed to the bench side research | 2024-09-30 | SE |
| Kornél Király | Glycine transporters as an emerging target in the treatment of chronic pain | 2024-09-30 | SE |
| Zoltán Kaló | Supporting health care R&D decisions by early phase technology assessment | 2024-09-30 | SE |
| Eszter Lajkó | Cell- and molecular biological investigation of small molecule drugs and their peptide conjugates designed for targeted tumor therapy | 2024-09-30 | SE |
| Donát Alpár | Heterogeneity and evolution of hematopoietic malignancies | 2024-11-01 | SE |
| Tamás Mihály Cserepes | Relations of hypoxia and acquired therapy resistance in solid tumors | 2024-11-01 | SE |
| Csaba Bödör | Clinicopathological analysis of myeloproliferative neoplasms | 2024-11-01 | SE |
| Kornélia Baghy | The role of the SPOCK1 proteoglycan in cancer development and progression | 2024-11-01 | SE |
| István Kenessey | Interaczion of tumor cell and environmental immune competent elements in human head and neck squamous cancer | 2024-11-01 | SE |
| István Kenessey | Changing in the epidemiology of malignancies in Hungary | 2024-11-01 | SE |
| Tibor Krenács | Molecular morphology monitoring of myelofibrosis progression and correlations between immunophenotype and genetic predisposition | 2024-11-01 | SE |
| Otília Menyhárt | Development of diagnostic tools by utulizing patient-derived medical data | 2024-11-01 | SE |
| Árpád Szállási | Tumor-associated Cardohydrate Antigen (TACA) expression in solid tumors: implications for immune checkpoint inhibitor therapy | 2024-11-01 | SE |
| Lilla Reiniger | Genomic and epigenomic background of chronic lymphocytic | 2024-11-01 | SE |
| Ágota Szepesi | Clinicopathology and molecular basis of cutaneous lymphoproliferative disorders. | 2024-11-01 | SE |
| Botond Timár | Comprehensive genetic and clinicopathological characterisation of myeloid neoplasias | 2024-11-01 | SE |
| Árpád Szállási | TRP channel expression in malignant tumors: implications for diagnosis, prognosis, a | 2024-11-01 | SE |
| András Kiss | The role of molecular pattern of cell adhesion molecules and microRNAs in the ethiopathogenesis of primary and metastatic liver tumors | 2024-11-01 | SE |
| András Kiss | Identification of molecular targets in liver tumors and corresponding biopsies and liquid samples | 2024-11-01 | SE |
| Gábor Lotz | Effect of Helicobacter pylori infection and other pathogenic agents on the pathogenesis of benign and malignant diseases of the stomach and other organs | 2024-11-01 | SE |
| Orsolya Dobay | Carriage, virulence and antibiotic resistance of Gram-positive bacteria | 2024-11-01 | SE |
| Béla Kocsis | Investigation of fluoroquinolone and polymyxin resistance mechanisms in Gram-negative bacteria | 2024-11-01 | SE |
| Dóra Szabó | The role of gut microbiota in different diseases | 2024-11-01 | SE |
| Zsolt Jurányi | Cytogenetic and immunological changes induced by radiation therapy in cancer patients. Mechanism of radiation resistance | 2024-11-01 | SE |
| Zoltán Takácsi-Nagy | Radiotherapy and radiochemotherapy of head and nack cancers | 2024-11-01 | SE |
| Bálint László Bálint | Oncogenomic aspects of gene expression regulation at the chromatin level | 2024-11-01 | SE |
| Hargita Hegyesi | Extracellular vesicle-mediated communication in experimental inflammatory models | 2024-11-01 | SE |
| Edina Dr. Némethné Dr. Gradvohl | The history of medical and health science in relation to bioethical issues | 2024-11-30 | SEETK |
| Imre Rurik | Obesity related research | 2024-11-30 | SEETK |
| Imre Rurik | Research on sexuality and mens’health | 2024-11-30 | SEETK |
| Éva Sztárayné Dr. Kézdy | Changing parental roles in today's Hungary | 2024-11-30 | SE |
| Nóra Sydó | Pharmacology and dietetics of extreme exercise and extreme environmental circumstances (spaceflight, defence) | 2024-12-31 | SE |
| Kornél Király | Investigation of angiotensin-opioid interactions in releation to opioid analgesia | 2024-12-31 | SE |
| Ádám Golcs | Development of high-throughput synthesis-supporting methods | 2024-12-31 | SE |
| Klementina Ocskay | Role of Exogenous and Endogenous Modifiers in the Development of Abnormal Glucose Tolerance in Cystic Fibrosis | 2024-12-31 | SE |
| Péter Csermely | The quantitative analysis ofepithelial-mesenchymal transition | 2024-12-31 | SE |
| Gergely Róna | Identifying small molecule inhibitors against human exonucleases to aid existing therapies in oncology. | 2024-12-31 | SE |
| Dániel Palkovics | Novel approaches in minimally invasive surgical periodontal therapy | 2025-02-01 | SE |
| Dániel Palkovics | 3D technology and artificial intelligence in periodontology and dento-alveolar rehabilitation | 2025-02-01 | SE |
| Zsolt István Bagyura | Examination of novel data collection and data utilization methods in the medical information technology | 2025-04-05 | SEETK |
| Zsuzsanna Németh | The role of complementary treatments in prevension of non-communicable diseases , moreover their effects on disease progression and efficiety of conventional treatment | 2025-04-05 | SEETK |
| István Gyertyán | Rodent models of cognitive dysfunctions in neurologic and psychiatric disorders | 2025-04-30 | SE |
| Johanna Takács | Assessment of cognitive functioning in different conditions | 2025-04-30 | SEETK |
| Mónika Fekete | The key to healthy aging: nutrition and disease prevention in an epidemiological context | 2025-05-30 | MONI |
| Marianna Török | Risk factors, pathological background and treatment options for of recurrent loss of pregnancy | 2025-05-31 | SE |
| Marianna Török | The role of vitamin D in the adaptation of the coronary network | 2025-05-31 | SE |
| Marianna Török | Exercise-training induced adaptation of different types of vessels | 2025-05-31 | SE |
| Szabolcs Várbíró | Endocrinological features, treatment options and pathomechanism of polycystic ovary syndrome | 2025-05-31 | SE |
| Gergely Varga | Plasma cell dyscrasias | 2025-05-31 | SE |
| Péter Andréka | Cardiovascular prevention in Hungary | 2025-05-31 | SE |
| Márta Medvecz | Multidisciplinary aspects of rare hereditary and acquired dermatological diseases | 2025-05-31 | SE |
| Balázs Mayer | Characterization and function of gamma-delta T cells in skin stem cell niches | 2025-05-31 | SE |
| Zsolt Megyesfalvi | Identification of subtype-specific diagnostic and predictive biomarkers in small cell lung cancer | 2025-05-31 | SE |
| István Vályi-Nagy | COVID-19: course, predictive and prognostic factors, diagnosis and therapy | 2025-05-31 | SE |
| Attila József Szabó | Long COVID syndrome in children | 2025-05-31 | SE |
| Tamás Kiss | Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events | 2025-05-31 | SE |
| Apor Veres-Székely | Investigating the pathomechanism of chronic diseases associated with pathological tissue remodeling and fibrosis | 2025-05-31 | SE |
| Zoltán Imre Pozsonyi | Cardiovascular aspects of the treatment of colorectal cancer | 2025-05-31 | SE |
| Gabriella Gálffy | Investigation of lung cancer mortality in the light of new diagnostic and therapeutic options and different biomarkers | 2025-05-31 | SE |
| Veronika Müller | Prognostic factors in intersitital lung diseases | 2025-05-31 | SE |
| Péter Holló | Investigating the pathomechanism and prognostic factors of tumours of the skin | 2025-05-31 | SE |
| István Seri | Definition and management of neonatal cardiovascular compromise utilizing the tools of precision medicine | 2025-05-31 | SE |
| Gábor Mikala | The effect of prognostic factors and measurable biomarkers on the therapeutic efficacy in multiple myeloma | 2025-05-31 | SE |
| Balázs Dezsényi | Clinical epidemiology of focal infective liver lesions | 2025-05-31 | SE |
| Péter Andréka | Factors affecting short -and long term outcome after transcatheter aortic valve implantation | 2025-05-31 | SE |
| Gabriella Gálffy | Factors influencing the treatment of obstructive pulmonary disease | 2025-05-31 | SE |
| Norbert Ferenc Kiss | Innovative multimodal imaging approaches in the field of dermatology and dermato-oncology | 2025-05-31 | SE |
| Lajos Vince Kemény | Investigation of the efficacy and side effects of immuncheckpoint blockade in melanoma and identification of novel therapeutic targets | 2025-05-31 | SE |
| Eszter Ostorházi | The role of skin, faeces, blood, urine and tissue microbiome in the development and progression of infective and non-infective diseases | 2025-05-31 | SE |
Login
